SSE: 688235 - BeiGene, Ltd.

Yield per half year: +41.11%
Sector: Healthcare

BeiGene, Ltd.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 41.44 -100% 0 0%
P/S 75.8 20.2 275.28%
P/BV 7.42 3.68 101.8%
P/FCF -85.93 82.02 -204.77%
Ev/Ebitda -14.72 16.62 -188.56%
Ev/S 551.81 25.64 2051.81%
Ev/FCF -108.98 85.08 -228.09%
E/P -0.000824 0.0217 -103.8%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-126.34 6.32 -2098.35% -223.37 -43.44%
ROE -3.19 6.65 -147.89%
ROA -2.07 3.59 -157.7%
ROIC 0 0 0%
ROS -35.86 -76.75 -53.28%
ROCE 0 19.43 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.0418 0.7406 -105.65% -0.9981 -95.81%
Nеt Debt/Ebitda -0.3006 -0.1122 167.96%
Debt/Ratio 0.0935 0.1008 -7.25%
Debt/Equity 0.0161 0.212 -92.39%
Debt/Net Income -4.37 1.37 -417.88%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.3991 -100% 0 0%
Number of years of dividend growth 0 1 -100%
DSI 0 0.6935 -100%
Average dividend growth 0 3.04 -100%
Average percentage for 5 years 0 1.4 -100%
Average percentage for payments 0 45.07 -100%
Difference from average difference in sector -0.3991

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-89.06 23.95 -471.86%
Growth impulse Ebitda in 5 years 75.22 12.85 485.37%
Growth impulse Net Income in 5 years -98.23 62.77 -256.49%
Growth impulse FCF in 5 years -73.85 30.35 -343.33%
Growth impulse EPS in 5 years -98.96 82.9 -219.37%
IP Score
2.47/10

Similar companies

Shanghai MicroPort MedBot (Group) Co., Ltd.

Shanghai Junshi Biosciences Co., Ltd.

Shanghai HeartCare Medical Technology Corporation Limited

Shanghai Henlius Biotech, Inc.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription